[go: up one dir, main page]

ATE348631T1 - Verwendung von plasminogen zur heilung von zerbrochenen trommelfellen - Google Patents

Verwendung von plasminogen zur heilung von zerbrochenen trommelfellen

Info

Publication number
ATE348631T1
ATE348631T1 AT02797695T AT02797695T ATE348631T1 AT E348631 T1 ATE348631 T1 AT E348631T1 AT 02797695 T AT02797695 T AT 02797695T AT 02797695 T AT02797695 T AT 02797695T AT E348631 T1 ATE348631 T1 AT E348631T1
Authority
AT
Austria
Prior art keywords
plasminogen
eartums
healing
relates
tympanic membrane
Prior art date
Application number
AT02797695T
Other languages
English (en)
Inventor
Tor Ny
Jinan Li
Sten Hellstrom
Per-Olof Eriksson
Original Assignee
Omnio Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Omnio Ab filed Critical Omnio Ab
Application granted granted Critical
Publication of ATE348631T1 publication Critical patent/ATE348631T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/484—Plasmin (3.4.21.7)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Manufacture Of Motors, Generators (AREA)
AT02797695T 2001-09-06 2002-09-06 Verwendung von plasminogen zur heilung von zerbrochenen trommelfellen ATE348631T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US31764301P 2001-09-06 2001-09-06

Publications (1)

Publication Number Publication Date
ATE348631T1 true ATE348631T1 (de) 2007-01-15

Family

ID=23234611

Family Applications (2)

Application Number Title Priority Date Filing Date
AT06126236T ATE552842T1 (de) 2001-09-06 2002-09-06 Verwendung von plasminogen zur wundheilung
AT02797695T ATE348631T1 (de) 2001-09-06 2002-09-06 Verwendung von plasminogen zur heilung von zerbrochenen trommelfellen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT06126236T ATE552842T1 (de) 2001-09-06 2002-09-06 Verwendung von plasminogen zur wundheilung

Country Status (9)

Country Link
US (3) US7067492B2 (de)
EP (2) EP1790354B1 (de)
CN (2) CN1289145C (de)
AT (2) ATE552842T1 (de)
AU (1) AU2002361878A1 (de)
DE (1) DE60216939T2 (de)
DK (2) DK1790354T3 (de)
ES (2) ES2387797T3 (de)
WO (1) WO2003020297A2 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7067492B2 (en) * 2001-09-06 2006-06-27 Omnio Ab Method of promoting healing of a tympanic membrane perforation
BRPI0612121A2 (pt) * 2005-06-30 2016-09-06 Anthrogenesis Corp método de reparo de uma membrana timpânica que tenha uma deformidade, e, biotecido de colágeno
US7842299B2 (en) * 2006-03-14 2010-11-30 Oregon Health & Science University Methods for producing an immune response to tuberculosis
WO2008021391A1 (en) 2006-08-15 2008-02-21 Anthrogenesis Corporation Umbilical cord biomaterial for medical use
CN101573134B (zh) 2006-08-28 2013-03-06 李季男 抗感染候选药物
WO2008027000A2 (en) * 2006-08-28 2008-03-06 Omnio Healer Ab Novel drug target of preventing and treating periodontal disease, improving healing of periodontal wounds and promoting oral health
US8071135B2 (en) 2006-10-04 2011-12-06 Anthrogenesis Corporation Placental tissue compositions
ES2516698T3 (es) 2006-10-06 2014-10-31 Anthrogenesis Corporation Composiciones de colágeno placentario (telopéptido) nativo
WO2008146224A2 (en) * 2007-05-25 2008-12-04 Compex Medical S.A. Wound healing electrode set
GB2450747A (en) * 2007-07-06 2009-01-07 Univ Sheffield Treatment of sensorineural hearing loss
EP2249863A4 (de) * 2008-01-22 2011-12-28 Omnio Healer Ab Verfahren zur verbesserung der wundheilung
RU2018146249A (ru) 2013-05-15 2019-01-18 Зе Боард Оф Трастиз Оф Зе Леланд Стэнфорд Джуниор Юниверсити Модуляция активности гепарин-связывающего эпидермального фактора роста для заживления барабанной перепонки
TWI801331B (zh) 2015-11-03 2023-05-11 美商波麥堤克生物治療股份有限公司 纖維蛋白溶酶原缺乏症之纖維蛋白溶酶原替代療法
TW201722464A (zh) * 2015-11-10 2017-07-01 波麥堤克生化科學有限公司 用於傷口癒合之纖維蛋白溶酶原給藥方案
CN109069567A (zh) 2015-12-18 2018-12-21 泰伦基国际有限公司 一种预防或治疗糖尿病性神经损伤及其相关病症的方法
JP6783870B2 (ja) 2015-12-18 2020-11-11 タレンゲン インターナショナル リミテッドＴａｌｅｎｇｅｎ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｌｉｍｉｔｅｄ 心血管病を予防及び治療するための新しい方法
WO2017101870A1 (zh) * 2015-12-18 2017-06-22 深圳瑞健生命科学研究院有限公司 一种预防或治疗糖尿病性视网膜病变的方法
US11090372B2 (en) 2015-12-18 2021-08-17 Talengen International Limited Method of treating diabetic nephropathy comprising administering plasminogen
CN108463236A (zh) * 2015-12-18 2018-08-28 泰伦基国际有限公司 一种预防或治疗放射性和化学性损伤的方法
TWI623321B (zh) 2015-12-18 2018-05-11 Talengen Institute Of Life Sciences Co Ltd Method for preventing and treating cervical erosion
TWI674903B (zh) * 2016-09-26 2019-10-21 國立陽明大學 製備改良豬血漿纖連蛋白以增強傷口癒合之應用
DK3556383T5 (da) 2016-12-15 2024-09-02 Talengen Int Ltd Plasminogen til anvendelse ved behandling af diabetes
US11478535B2 (en) * 2016-12-15 2022-10-25 Talengen International Limited Method for preventing and treating fatty liver
WO2018107707A1 (zh) * 2016-12-15 2018-06-21 深圳瑞健生命科学研究院有限公司 一种改善心脏病变的方法
CN108210897A (zh) * 2016-12-15 2018-06-29 深圳瑞健生命科学研究院有限公司 预防和治疗肺纤维化的药物及其用途
CN108339114A (zh) * 2016-12-15 2018-07-31 深圳瑞健生命科学研究院有限公司 抑制胰岛β细胞凋亡的药物及其用途
CA3046666A1 (en) * 2016-12-15 2018-06-21 Talengen International Limited Method for preventing and treating tissue and organ fibrosis
TW201829448A (zh) 2016-12-15 2018-08-16 大陸商深圳瑞健生命科學硏究院有限公司 纖溶酶原在製備預防或治療肥胖症及疾病倂發的肥胖的藥物中的用途
EP3643321A4 (de) 2017-06-19 2021-05-05 Talengen International Limited Verfahren zur regulierung und steuerung von glp-1/glp-1r und arzneimittel
AR124640A1 (es) * 2020-11-25 2023-04-19 Grifols Worldwide Operations Ltd Cicatrización de heridas

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU647391B2 (en) * 1989-05-01 1994-03-24 University Of Notre Dame Du Lac, The Methods and materials for expression of human plasminogen in a eukaryotic cell system
US6559119B1 (en) * 1990-11-27 2003-05-06 Loyola University Of Chicago Method of preparing a tissue sealant-treated biomedical material
US6197325B1 (en) * 1990-11-27 2001-03-06 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
ATE226089T1 (de) 1995-01-27 2002-11-15 Tno Verwendung einer zubereitung enthaltend einen plasminogen-aktivator für die verbesserung der wundheilung
WO1996041818A1 (en) 1995-06-09 1996-12-27 Drohan William N Chitin hydrogels, methods of their production and use
US6043407A (en) 1997-07-29 2000-03-28 Warner-Lambert Company Debridement pad
WO2000031244A1 (en) * 1998-11-25 2000-06-02 Bristol-Myers Squibb Company Compositions comprising angiostatin and kringle 5 region of plasminogen and methods of use thereof
WO2000061179A1 (en) * 1999-04-14 2000-10-19 Karolinska Innovations Ab Kringle domains of plasminogen, capable of modulating angiogenesis in vivo
US7067492B2 (en) 2001-09-06 2006-06-27 Omnio Ab Method of promoting healing of a tympanic membrane perforation
US7202066B2 (en) * 2002-01-29 2007-04-10 Carrington Laboratories, Inc. Combination of a growth factor and a protease enzyme

Also Published As

Publication number Publication date
DE60216939T2 (de) 2007-10-04
CN1289145C (zh) 2006-12-13
US8637010B2 (en) 2014-01-28
ES2279001T3 (es) 2007-08-16
WO2003020297A3 (en) 2003-10-09
ATE552842T1 (de) 2012-04-15
CN1585649A (zh) 2005-02-23
US20070041962A1 (en) 2007-02-22
WO2003020297A8 (en) 2004-07-08
US8679482B2 (en) 2014-03-25
CN1961958B (zh) 2011-05-18
US7067492B2 (en) 2006-06-27
US20080090751A1 (en) 2008-04-17
EP1790354B1 (de) 2012-04-11
WO2003020297A2 (en) 2003-03-13
AU2002361878A1 (en) 2003-03-18
CN1961958A (zh) 2007-05-16
EP1427440B1 (de) 2006-12-20
ES2387797T3 (es) 2012-10-01
US20030147879A1 (en) 2003-08-07
EP1790354A3 (de) 2007-10-24
DK1427440T3 (da) 2007-04-30
DE60216939D1 (de) 2007-02-01
EP1790354A2 (de) 2007-05-30
DK1790354T3 (da) 2012-07-23
EP1427440A2 (de) 2004-06-16

Similar Documents

Publication Publication Date Title
ATE348631T1 (de) Verwendung von plasminogen zur heilung von zerbrochenen trommelfellen
ATE376446T1 (de) Verwendung von n-hydroxyalkyl-o-benzylchitosanen zur haarbehandlung
DE60137430D1 (de) Gewebeimplant zur wiederherstellung von knorpelgewebe
DK1545587T3 (da) Lactoferrinsammensætninger og fremgangsmåder til behandling af diabetiske sår
DE60101669T2 (de) Verwendung von botulinum-toxin zur behandlung von diabetes
CY1111536T1 (el) Μεθοδοι και συνθεσεις για την καταστολη της διαφοροποιησης ινοκυτταρων
ATE419856T1 (de) Verwendung von rimexolon zur behandlung von augentrockenheit
EP1534074A4 (de) Kombinationstherapie zur behandlung von fettleibigkeit
DE60112807D1 (de) Zusammensetzung zur behandlung von durch arterielle irrigationsdefekt gewebeschäden
ATE296628T1 (de) Integrinhemmer zur behandlung von augenkrankheiten
ATE515268T1 (de) Verwendung von op-1 zur behandlung von knorpeldefekten
DE60130661D1 (de) Verwendung der 13-cis retinsäure zur behandlung von emphysemen
ATE402699T1 (de) Verwendung von substituierten pyrazolen zur behandlung von allergien
DE60237039D1 (de) Verfahren zur behandlung von rosacea und telangiectasia
DE60212143D1 (de) Verwendung von thrombin-peptidderivaten zur behandlung von chronischen hautulcera
DE60218153D1 (de) Verwendung von proteasom-inhibitoren zur behandlung des trockenen auges
DE50105735D1 (de) Chlorzoxazon zur behandlung von psoriasis
ATE402694T1 (de) Verwendung von 1-phenyl-3-dimethylamino-propan- verbindungen zur therapie der harninkontinenz
DE50205466D1 (de) Substituierte 2,5-diamidoindole als ece-inhibitoren zur behandlung von kardiovaskulären erkrankungen
ATE264101T1 (de) Verwendung von thioamidoxazolidinonen zur behandlung von knochenresorption und osteoporose
DE50212649D1 (de) Verwendung von desoxypeganin zur behandlung der klinischen depression
ATE314066T1 (de) Verwendung von buprenorphin zur therapie der harninkontinenz
ATE359088T1 (de) Verwendung von interleukin-18 zur behandlung von uv-assoziierten hautkrankheiten
ATE353666T1 (de) Verwendung von aktiviertem gerinnungsfaktor vii zur behandlung von durch thrombolytische therapie-induzierten wichtigen blutungen
DE59805246D1 (de) Tissue-faktor zur beeinflussung von gefässbildung

Legal Events

Date Code Title Description
EEIH Change in the person of patent owner
UEP Publication of translation of european patent specification

Ref document number: 1427440

Country of ref document: EP